SCHEMBL29648378

SCHEMBL29648378

CCC(C)c1ccc(Nc2ccc(S(=O)(=O)N(C)Cc3ccc(OC)cc3)cc2-c2cn(C)cn2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.37
▸ YAP1 P46937 1/20 0.37
▸ KAT8 Q9H7Z6 6/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPK8 P45983 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ BMP1 P13497 2/20 0.34
▸ KAT6A Q92794 1/20 0.34
▸ NR1H2 P55055 1/20 0.33
▸ NR1H3 Q13133 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ACLY P53396 1/20 0.33
▸ MMP2 P08253 1/20 0.32
▸ MMP9 P14780 1/20 0.32
▸ MMP8 P22894 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24495998 1.00 TEAD1 (0.37) TEAD1YAP1KAT8L3MBTL1MEN1
SCHEMBL24496012 0.93 BMP1 (0.39) TEAD1YAP1KAT8L3MBTL1MEN1
SCHEMBL29648428 0.93 BMP1 (0.39) TEAD1YAP1KAT8L3MBTL1MEN1
SCHEMBL24496182 0.89 TEAD1 (0.39) TEAD1YAP1KAT8MEN1KMT2A
SCHEMBL29648333 0.89 TEAD1 (0.39) TEAD1YAP1KAT8MEN1KMT2A
SCHEMBL24495997 0.87 TSHR (0.38) TEAD1YAP1KAT8L3MBTL1MEN1
SCHEMBL29648312 0.87 TSHR (0.38) TEAD1YAP1KAT8L3MBTL1MEN1
SCHEMBL22718097 0.85 TEAD1 (0.42) TEAD1YAP1KAT8MEN1KMT2A
SCHEMBL22718047 0.85 TEAD1 (0.42) TEAD1YAP1KAT8MEN1KMT2A
SCHEMBL24496062 0.85 TEAD1 (0.37) TEAD1YAP1KAT8L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 — — WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
Send feedback